z-logo
open-access-imgOpen Access
P107: A PHASE 2/3, RANDOMIZED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED STUDY OF MITAPIVAT IN PATIENTS WITH SICKLE CELL DISEASE
Author(s) -
Howard J,
Kuo K,
Oluyadi A,
Shao H,
Morris S,
Zaidi A,
Van Beers E,
Thein S
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000821520.36794.7d
Subject(s) - medicine , hemolysis , pyruvate kinase deficiency , placebo , sickle cell anemia , priapism , anemia , gastroenterology , acute chest syndrome , disease , surgery , pyruvate kinase , glycolysis , pathology , alternative medicine , metabolism

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here